Intravenous Administration of Microplasmin for Treatment of Acute Ischemic Stroke

Completed

Phase 2 Results

Summary of Purpose

The primary purpose of this study is to evaluate the safety and preliminary efficacy of microplasmin when administered intravenously to patients who have suffered an acute stroke within 12 hours before randomization.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 6 November 2014.

1 Oct 2005 21 Jul 2005 1 May 2008 1 Jun 2008 1 Nov 2014 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Investigator)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available